Instil Bio, Inc. Increase (Decrease) in Other Noncurrent Assets
Instil Bio, Inc. (TIL) reported Increase (Decrease) in Other Noncurrent Assets of -$160.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-13
- Instil Bio, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$80.00K.
- Instil Bio, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$80.00K.
- Instil Bio, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$80.00K, a 106.41% decline year-over-year.
- Instil Bio, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$94.00K, a 104.25% decline year-over-year.
- Instil Bio, Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was -$425.00K, a 109.74% decline from fiscal 2024.
- Instil Bio, Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was $4.36M.
- Instil Bio, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was -$1.54M.
- Instil Bio, Inc. increase (decrease) in other noncurrent assets for fiscal 2022 was -$354.00K, a 105.44% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 3 month as first filed | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 6 month as first filed | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month | Increase (Decrease) in Other Noncurrent Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$160.00K 10-Q · filed 2026-08-13 | -$240.00K derived: sum of 3 quarters · filed 2026-08-13 | -$334.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | -$80.00K 10-Q · filed 2026-05-15 | -$160.00K derived: sum of 2 quarters · filed 2026-05-15 | -$254.00K derived: sum of 3 quarters · filed 2026-05-15 | -$425.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | -$80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$174.00K derived: sum of 2 quarters · filed 2026-03-27 | -$345.00K derived: sum of 3 quarters · filed 2026-08-13 | -$425.00K 10-K · filed 2026-03-27 | |||
| 2025-09-30 | -$94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$265.00K derived: sum of 2 quarters · filed 2026-08-13 | -$345.00K 10-Q · filed 2025-11-13 | $903.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | -$171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$251.00K 10-Q · filed 2026-08-13 | $2.44M 10-Q · filed 2025-08-13 | $997.00K derived: sum of 3 quarters · filed 2026-08-13 | $3.21M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | -$80.00K 10-Q · filed 2026-05-15 | $1.31M 10-Q · filed 2025-05-13 | $1.17M derived: sum of 2 quarters · filed 2026-05-15 | $3.38M derived: sum of 3 quarters · filed 2026-05-15 | $4.09M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $3.46M derived: sum of 2 quarters · filed 2026-03-27 | $4.17M derived: sum of 3 quarters · filed 2026-03-27 | $4.36M 10-K · filed 2026-03-27 | $8.63M 10-K · filed 2025-03-04 | ||
| 2024-09-30 | $2.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.92M derived: sum of 2 quarters · filed 2025-11-13 | $3.12M 10-Q · filed 2025-11-13 | $1.85M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | $704.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $901.00K 10-Q · filed 2025-08-13 | -$367.00K derived: sum of 3 quarters · filed 2025-08-13 | -$1.66M derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | $197.00K 10-Q · filed 2025-05-13 | -$1.07M derived: sum of 2 quarters · filed 2025-05-13 | -$2.36M derived: sum of 3 quarters · filed 2025-05-13 | -$1.28M derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | -$1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$2.56M derived: sum of 2 quarters · filed 2025-03-04 | -$1.48M derived: sum of 3 quarters · filed 2025-03-04 | -$1.54M 10-K · filed 2025-03-04 | |||
| 2023-09-30 | -$1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$208.00K derived: sum of 2 quarters · filed 2024-11-13 | -$275.00K 10-Q · filed 2024-11-13 | -$2.71M derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $1.02M 10-Q · filed 2024-08-13 | -$1.41M derived: sum of 3 quarters · filed 2024-08-13 | -$791.00K derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | -$67.00K 10-Q · filed 2024-05-10 | -$2.50M derived: sum of 2 quarters · filed 2024-05-10 | -$1.88M derived: sum of 3 quarters · filed 2024-05-10 | -$712.00K derived: sum of 4 quarters · filed 2024-05-10 | |||
| 2022-12-31 | -$2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$1.81M derived: sum of 2 quarters · filed 2024-03-21 | -$645.00K derived: sum of 3 quarters · filed 2024-03-21 | -$354.00K 10-K · filed 2024-03-21 | |||
| 2022-09-30 | $622.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.78M derived: sum of 2 quarters · filed 2023-11-13 | $2.08M 10-Q · filed 2023-11-13 | $5.42M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.45M 10-Q · filed 2023-08-14 | $4.80M derived: sum of 3 quarters · filed 2023-08-14 | $6.42M derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $291.00K 10-Q · filed 2023-05-11 | $3.63M derived: sum of 2 quarters · filed 2023-05-11 | $5.26M derived: sum of 3 quarters · filed 2023-05-11 | $4.58M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $4.97M derived: sum of 2 quarters · filed 2023-03-31 | $4.29M derived: sum of 3 quarters · filed 2023-03-31 | $6.50M 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $944.00K derived: sum of 2 quarters · filed 2022-11-14 | $3.16M 10-Q · filed 2022-11-14 | $4.27M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | -$685.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $1.53M 10-Q · filed 2022-08-12 | $2.64M derived: sum of 3 quarters · filed 2022-08-12 | $2.66M derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2021-03-31 | $2.22M 10-Q · filed 2022-05-16 | $3.33M derived: sum of 2 quarters · filed 2022-05-16 | $3.35M derived: sum of 3 quarters · filed 2022-05-16 | $3.35M derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $1.13M derived: sum of 2 quarters · filed 2022-03-07 | $1.13M derived: sum of 3 quarters · filed 2022-03-07 | $1.14M 10-K · filed 2022-03-07 | |||
| 2020-09-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $21.00K derived: sum of 2 quarters · filed 2021-11-15 | $29.00K 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $8.00K 10-Q · filed 2021-08-12 | |||||
| 2020-03-31 | $8.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |